As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn by the manufacturers due to a higher rate of allergic/hypersensitivity type reactions, some of which were considered medically significant.

http://www.fda.gov/safety/medical-product-safety-information/immune-globulin-intravenous-igiv-and-immune-globulin-subcutaneous-igsc-voluntary-lot-withdrawals-due